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Abstract Werner’s syndrome is a rare disease of premature
ageing. The WRN gene product defective in this disorder be-
longs to the RecQ helicase family and is thought to be involved
in DNA metabolism. Another protein, which plays an important
role in both DNA replication and repair, is the poly-ADP ribo-
syl transferase. Here we demonstrate an interaction of these two
proteins resulting in ADP-ribosylation of the WRN protein.
These results imply that WRN is involved in DNA replication
and in DNA repair.
# 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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1. Introduction
Werner’s syndrome (WS) is a progeroid disorder of the
adult, characterized by premature ageing [1,2]. Cells from
these patients show chromosomal instability [3^5], and a pro-
longed S-phase [6].
The gene product, WRN, was shown to have an ATPase
activity, a 3PC5P helicase activity [7] as well as a 3PC5P
exonuclease activity [8,9]. In which kind of cellular processes
the protein participates is unknown, recombination, replica-
tion and repair are candidates.
The WRN helicase is able to unwind fork structures, RNA/
DNA duplexes and alternative DNA structures including tet-
raplex and triplex DNA, ‘bubbles’ and Holliday junctions
[10^15]. The WRN exonuclease has been reported to digest
some of the double stranded intermediate DNA substrates,
unwound by the helicase, for example tetraplex and triplex
DNA [16].
Several interaction proteins have been reported for WRN.
Most of them, such as proliferating cell nuclear antigen
(PCNA) [17], DNA polymerase N [9], replication protein A
(RPA) [18], and £ap endonuclease 1 (FEN-1) [19], participate
in DNA replication and repair. A protein also involved in
these two processes is the poly-ADP ribosyl transferase
(pADPRT). It is known that this enzyme is activated in the
presence of DNA strand breaks. Upon activation pADPRT
transfers ADP ribose units from NADþ onto itself and other
proteins, thereby mostly inactivating the target protein [20].
pADPRT was shown to be a component of the multipro-
tein DNA replication complex (MRC) [21]. This complex
among others also contains some proteins interacting with
WRN. We therefore anticipated that pADPRT might be a
potential interaction protein for WRN. Here we report that
WRN indeed physically interacts with pADPRT and becomes
ADP-ribosylated in the presence of DNA breaks.
2. Materials and methods
2.1. Chemicals and antibodies
All chemicals were purchased from Merck, Roth or Sigma unless
otherwise indicated.
Polyclonal WRN antibodies against the N-terminal fragment, rep-
resenting the ¢rst 411 amino acids, and pADPRT antibodies against
the DNA binding domain were raised in rabbits and puri¢ed against
the antigens over a cyanobromide-activated Sepharose column.
2.2. Cell lines and culture conditions
Cell lines used: Wi38 was purchased from the American Type Cul-
ture Collection, KoHe and LW4 [22] were established by M. Hirsch-
Kau¡mann, Innsbruck, Austria from skin biopsies.
The cells were grown in minimal essential medium (MEM-Earle)
with 10% fetal calf serum (Biochrom AG, Germany) and cultivated at
37‡C in an atmosphere of 5% CO2 in air. All cells were free of my-
coplasms.
2.3. Coimmunoprecipitation
Nuclear extract (220 Wg), isolated as described [23], was incubated
with 5 Wg pADPRT antibodies. The precipitate was loaded onto a 6%
sodium dodecyl sulfate (SDS)^polyacrylamide gel and was used for a
Western blot following electrophoresis. The blot was incubated with
rabbit anti-WRN antibodies. Alkaline phosphatase-conjugated anti-
rabbit antibodies were used for detection.
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Fig. 1. Immunoprecipitation of WRN with pADPRT antibodies.
Nuclear extract (NE) from Wi38 is loaded on the left lane to locate
the WRN protein, and the immunoprecipitate (IP) is loaded on the
right one. The arrow points to the WRN protein band detected by
WRN antibodies. Middle lane: marker band of MW 204 000 (M).
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2.4. Western blot
Nuclear extracts (60 Wg protein) were fractionated in 10% SDS^
polyacrylamide gel electrophoresis (PAGE) and subsequently blotted
onto a nitrocellulose membrane (Schleicher and Schuell). Ponceau
S staining was used to con¢rm uniform protein loading. The blots
were probed with anti-WRN and anti-pADPRT antibodies, and im-
munoreactive complexes were analyzed with alkaline phosphatase-
conjugated anti-rabbit antibodies.
2.5. Blot overlay
Nuclear extract or the WRN N-terminal fragment was loaded onto
a 6% SDS^polyacrylamide gel. After electrophoresis the gel was blot-
ted onto a nitrocellulose membrane. The blot was stained with Pon-
ceau S and the lanes dedicated to be blot overlaid were cut o¡. Those
lanes were blocked in overlay bu¡er (50 mM Tris^HCl pH 7.5, 0.5%
bovine serum albumin, 0.25% gelatin, 0.2% Triton X-100, 2.5 mM
L-mercaptoethanol) for 4 h at 4‡C. Puri¢ed pADPRT in overlay bu¡-
er was allowed to incubate overnight at 4‡C. The membranes were
washed four times with Tris-bu¡ered saline at room temperature be-
fore a Western blot was performed using WRN antibodies.
2.6. ADP-ribosylation assay
Nuclear extract (50 Wg) from Wi38 ¢broblasts or 5 Wg WRN N-ter-
minal fragment was incubated with 1 Wg soni¢ed herring sperm DNA,
1 WCi [32P]NADþ and in the case of the WRN fragment with 5 Wg
recombinant pADPRT at 30‡C for 20 min. The probes were used for
SDS^PAGE. The wet gel was exposed to a phosphoimager screen,
which was developed by a phosphoimager.
3. Results
Since it was hypothesized that both WRN and pADPRT
are involved in DNA replication and DNA repair we were
interested in investigating a possible interaction between these
proteins. Actually, we could demonstrate an interaction by
means of a coimmunoprecipitation (Fig. 1). In the right lane
(immunoprecipitate, IP) the antibodies identi¢ed a protein
with the size of WRN (MW 160 000). The left lane shows
the endogenous position of the WRN protein in nuclear ex-
tracts.
This interaction was con¢rmed by blot overlay. Nuclear
extract or the puri¢ed N-terminal fragment of WRN was
loaded on an SDS^polyacrylamide gel, blotted onto nitrocel-
lulose membranes and stained with Ponceau S. The blots were
cut into two parts. One part was directly used for a Western
blot, developed with WRN antibodies; the second part was
incubated with puri¢ed pADPRT before a Western blot was
performed and developed with pADPRT antibodies. When
comparing the Western blots developed with WRN antibodies
and the blot overlay developed with pADPRT antibodies, a
protein of the size of WRN could be detected in both blots
(Fig. 2A). That this interaction was not restricted to embry-
onic lung ¢broblasts (Wi38) could be proved by the use of
Fig. 2. Blot overlay (BO) experiments to detect an interaction between WRN and pADPRT. A: Nuclear extracts were loaded on a gel and
blotted onto a nitrocellulose membrane. Left lane: WRN and other pADPRT-interacting proteins detected by pADPRT antibodies after incu-
bation of the gel with puri¢ed pADPRT (BO). Right lane: Western blot (WB). WRN directly detected with WRN antibodies. B: Same proce-
dure as in A using an N-terminal fragment of WRN (WRN-N). Left lane: Western blot (WB) of the puri¢ed fragment. Right lane: blot over-
lay (BO).
Fig. 3. ADP-ribosylation of WRN. A: Nuclear extract from Wi38 was incubated with [32P]NADþ and soni¢ed herring sperm DNA, loaded on
a gel, and following electrophoresis exposed to a phosphoimager screen plate (AR). The bands were compared with the WRN bands on the
Western blot (B) derived from the same gel. Left lane: ADP-ribosylation probe (AR). Right lane: Nuclear extract (NE). Arrows indicate WRN
bands. C: ADP-ribosylation of the N-terminal WRN fragment (WRN-N).
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material from other tissues such as primary skin ¢broblasts
and blood cells (data not shown). The blot overlay of the
N-terminal WRN fragment with pADPRT antibodies also
resulted in a positive signal (Fig. 2B).
Being aware of an interaction between WRN and pADPRT
the question arose whether WRN was modi¢ed by pADPRT.
Therefore an ADP-ribosylation assay was performed. Nuclear
extracts were incubated with [32P]NADþ together with soni-
¢ed herring sperm DNA, in order to activate the endogenous
pADPRT. After SDS^PAGE the wet gel was exposed to a
phosphoimager screen plate and blotted thereafter. On the
phosphoimage (Fig. 3A) a couple of 32P-labelled bands could
be distinguished. To clarify if one of the bands represents
WRN, we used the gel to perform a Western blot and devel-
oped the proteins with WRN antibodies (Fig. 3B). Compar-
ison of the blot with the phosphoimage revealed one of the
radioactively labeled bands to be WRN. An ADP-ribosylation
assay was also performed with the puri¢ed N-terminal WRN
fragment. In this case pADPRT activity was recruited by
puri¢ed recombinant pADPRT instead of nuclear extracts.
As seen in Fig. 3C the WRN fragment was ADP-ribosylated
too.
Since WRN and pADPRT apparently interact but WS cells
do not have any functioning WRN protein, we investigated if
the amount of pADPRT in cells derived from WS patients
di¡ered from that of control cells. We isolated nuclear ex-
tracts from both con£uent and logarithmically growing cells
from controls and from authentic WS ¢broblasts [22]. In com-
parison to the control cell line we could detect a reduction of
pADPRT in the WS cell line at con£uency (Fig. 4).
4. Discussion
The nuclear proteins WRN and pADPRT are both related
to central cellular processes. pADPRT has been identi¢ed for
instance as a component of MRC [21] and WRN copuri¢es
with this complex [17]. Here we could show the direct inter-
action of these two proteins in human embryonic lung ¢bro-
blasts (Wi38), a result that was very recently veri¢ed by a
report by Lebel and coworkers [24] using embryonic kidney
cells. Our own results obtained with other tissues point to the
importance and universality of this interaction.
pADPRT ADP-ribosylates several components of the
MRC, for instance RNA polymerase K, topoisomerase I
and PCNA. This modi¢cation is purposed both to regulate
the activity of the proteins during replication and to regulate
the composition of the MRC. Here, to our knowledge for the
¢rst time, we document that pADPRT is also able to ADP-
ribosylate WRN. Some components of the MRC such as
RPA, FEN-1 and DNA polymerase N have been shown to
interact with WRN [17^19,25]. This, together with the fact
that WRN has been located to sites of replication in the
nucleoli [25^27], points to a role of WRN in replication.
ADP-ribosylation of WRN may regulate its participation in
this process.
Since we [22,28] and others [29^32] have shown that cells
from patients su¡ering from WS are sensitive to X-ray, alky-
lating agents, etc., it was proposed that WRN is also involved
in repair processes. The most probable repair pathway WRN
participates in is the non-homologous end joining (NHEJ).
This repair pathway is used in the repair of DNA double
strand breaks. Thereby, WRN interacts with Ku70/80
[33,34], a component of the NHEJ, which stimulates the exo-
nuclease activity of WRN [35].
ADP-ribosylation of diverse proteins in the presence of free
DNA strand breaks tends to result in modi¢cation of their
activities in DNA replication or repair [36^39]. The ADP-ri-
bosylation of WRN as a participant in replication and repair
therefore may act as a switch signal for WRN to stop its
engagement in the replication machinery for the sake of be-
coming part of the repair process. This, for instance, could be
achieved by inactivation of the helicase activity and activation
of the exonuclease activity of the WRN protein following
ADP-ribosylation.
The interaction between WRN and pADPRT entails a dim-
inution of pADPRT in WRN-de¢cient ¢broblasts. This may
explain both the delayed induction of p53 after DNA damage
and the attenuation of p53-mediated apoptosis in WS cells
[40,41]. Increasing chromosomal instability and cancer-prone-
ness are disastrous consequences.
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